Fill Finish Biopharmaceuticals market, Industry Analysis, and Forecast to 2035 Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products. This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities. The financial opportunity within the biologics fill finish services market has been analysed across the following segments:  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Biologic  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Proteins / Peptides  Vaccines  Others  Therapeutic Area  Oncological Disorders  Autoimmune Disorders  Infectious Diseases  Cardiovascular Disorders  Other Disorders  Scale of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:  AbbVie Contract Manufacturing  Asymchem  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  Fareva  Fresenius Kabi  Glaxo SmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pierre Fabre  Recipharm  Samsun Biologics  Syngene  Takara Bio  Wacker Biotech  WuXi AppTec  WuXi Biologics Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Biologics Fill / Finish Service Providers: Market Landscape 5. Company Competitiveness Analysis 6. Biologics Fill / Finish Service Providers in North America 7. Biologics Fill / Finish Service Providers in Europe 8. Biologics Fill / Finish Service Providers in Asia-Pacific 9. Recent Partnerships 10. Recent Expansions 11. Capacity Analysis 12. Demand Analysis 13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish 14. Regional Capability Assessment 15. Biologics Fill Finish Market Sizing and Opportunity Analysis 16. Future Growth Opportunities 17. Case Study: Robotic Systems in Fill / Finish Operations 18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish 19. Concluding Remarks 20. Executive Insights 21. Appendix 1: Tabulated Data 22. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html News article women's digital health market Learn from experts: do you know about these emerging industry trends? Bioavailability Enhancement Technologies TIL Therapies: A New Paradigm in Cancer Treatment Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #FillFinishBiopharmaceuticalsMarketGrowth#FillFinishBiopharmaceuticalsMarketTrends#Fillfinishmarket#FillFinishManufacturingMarket#FillFinishServiceMarket

Cell Free Expression market, Size and Share by 2035 The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.” The cell free market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:  An executive summary of insights captured during our research.  A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique  A detailed assessment of the current market landscape of cell free expression service providers.  A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.  A comprehensive company competitiveness analysis of cell free expression service providers.  A product competitiveness analysis of cell free expression kits based on various relevant parameters.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.  Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).  A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.  An analysis of the funding and investments made in the cell free expression market, since 2018.  An in-depth analysis of various patents that have been filed / granted related to cell free systems since 2015.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Cell Free System • Crude Cell Lysate-based Systems • Reconstituted Systems  Type of Host Organism • Microbial Cell Free Expression System • Mammalian Cell Free Expression Systems • Plant-based Cell Free Expression Systems • Other Cell Free Expression Systems  Type of Expression Method • Coupled Transcription and Translation Method • Translation Method  End-User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Other End-Users  Key Geographical Regions • North America • Europe • Asia Pacific • Rest of the World Key companies covered in the report  BioLinker  biotechrabbit  CellFree Sciences  Creative Biolabs  CUSABIO  Daicel Arbor Biosciences  LenioBio  Promega  Thermo Fisher Scientific  Touchlight For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html Learn from experts: do you know about these emerging industry trends? Digital Therapies: The “Digital Pills” of current generation Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellFreeExpressionMarketTrends #CellFreeExpressionMarketGrowth #cellfreeproteinexpressionsystem #biomanufacturing #cellfreeexpressionsystem

Analysis of DNA Encoded Library market Strategies and Forecasts to 2035 The DNA encoded library market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors. This can be attributed to the various benefits offered by these platforms, such as cost effectiveness, high diversity, minimal false positives, stability and rapid hit identification. The financial opportunity within the DNA encoded library market has been analyzed across the following segments:  Application Area  Hit Generation / Identification  Hit to Lead  Hit Validation / Optimization  Other Application Areas  Therapeutic Area  Oncological Disorders  Immunological Disorders  Neurological Disorders  Respiratory Disorders  Dermatological Disorders  Cardiovascular Disorders  Infectious Diseases  Other Therapeutic Areas  End-user  Pharma / Biopharma Industry  Academic / Research Institute  Other End-users  Type of Payment Model Employed  Upfront Payment  Milestone Payment  Key Geographical Regions  North America  Europe  Asia-Pacific The research also includes detailed profiles of key players (listed below) offering DNA encoded library platforms and services; each profile features a brief overview of the company, its financial information (if available), details on platform and service portfolio, recent developments and an informed future outlook.  AlphaMa  DICE Therapeutics  DyNAbind  HitGen  NovAliX  Vipergen  WuXi AppTec  X-Chem Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Business Model Analysis 6. Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Global Event Analysis 10. Patent Analysis 11. Big Pharma Initiatives 12. Case Study: Companies / Organizations Supporting the Development of DNA Encoded Libraries 13. Market Forecast and Opportunity Analysis 14. Concluding Remarks 15. Executive Insights 16. Appendix 1: Tabulated Data 17. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/dna-encoded-libraries/288.html Learn from experts: do you know about these emerging industry trends? Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DNAEncodedLibraryMarketTrends #DNAEncodedLibraryMarketGrowth #dnaencodedlibraries #DELTechnology #xchem

Digital Biomanufacturing market 2023 – Industry Growth by 2035 Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics and process optimization to transform the available information into actionable insights. In the near future, this industry is anticipated to witness more investment and collaborations, while greater skillset among employees and adequate knowledge on operation will result in widespread adoption in the long run. Over 85% of the process analytical technologies are capable of offering process automation and bioprocess optimization and controls; majority of these platforms support manufacturing of proteins and antibodies. The financial opportunity associated with the digital manufacturing market has been analyzed across the following segments:  Type of Technology  Process Analytical Technology (PAT)  Data Analysis Software (DAS)  Manufacturing Execution Systems (MES)  Digital Twins  Deployment Options  Cloud-based Deployment Options  On-premises Deployment Options  Type(s) of Biologic(s) Manufactured  Antibodies  Cell and Gene Therapies  Proteins  Vaccines  Others  Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North America The Digital Biomanufacturing Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  AspenTech  Bioreactors.net  Dassault Systèmes  FUJIFILM Diosynth Biotechnologies  GE Healthcare  Körber  Merck  Sartorius  Thermo Fisher Scientific Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Technology Competitiveness Analysis 6. Company Profiles 7. Benchmarking Analysis 8. Partnerships and Collaborations 9. Market Concentration Analysis 10. Industry Lifecycle Analysis 11. Market Forecast and Opportunity Analysis 12. Concluding Remarks 13. Interview Transcripts 14. Appendix I: Tabulated Data 15. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html Learn from experts: do you know about these emerging industry trends? Applications of Blockchain in Various Sectors: An Introduction Intracellular Drug Delivery – Future Potential Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #ProcessAnalyticalTechnologymarket #digitalmanufacturingcompanies

Opportunities in RNA Therapeutics market Growth Analysis and Forecast by 2035 RNA therapies have emerged as a promising treatment modality, with the potential to target and alter genes, modulate protein functions and broaden the range of druggable targets, thereby paving way for new avenues in disease diagnosis and treatment. With rise in government initiatives for early commercialization of pipeline therapies and active involvement of RNA therapeutics investors, we anticipate a variety of novel RNA based therapeutics to be developed, presenting lucrative opportunities for both short- and long-term investors. The financial opportunity within the RNA therapeutics market has been analyzed across the following segments:  Type of Therapy  mRNA Vaccines and Therapeutics  RNAi Therapeutics  RNA Aptamers  Therapeutic Area  Infectious Diseases  Genetic Disorders  Haematological Disorders  Metabolic Disorders  Ocular Disorders  Oncological Disorders  Renal Disorders  Route of Administration  Intradermal  Intramuscular  Intravenous  Intravitreal  Ophthalmic  Subcutaneous  Key Geographies  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Investor Series: Opportunities in the RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers), detailed profiles of key public ventures engaged in the development of RNA therapeutics; each profile features a brief overview of the company, along with information on its management team, insights from its balance sheet (if available), as well as details related to its product portfolio, recent developments and key financials (including company investment highlights, company fundamental and company technical analysis).  Arcturus Therapeutics  Ascletis Pharma  Avidity Biosciences  BioNtech  CanSino Biologics  Gritstone bio  IVERIC bio  Moderna  Phio Pharmaceuticals  Vir Biotechnology Table of Contents Excel Deliverables 1. Innovators and Products Dataset 2. RNA therapeutics Funding and Investment Analysis 3. Company Valuation Analysis 4. Fundamental Financial Analysis 5. Technical Financial Analysis 6. Business Risk Analysis 7. Market Forecast and Opportunity Analysis 8. Return on Investment PowerPoint Deliverable 1. Context 2. Project Approach 3. Project Objective 4. Executive Summary Section I: Introduction to RNA Therapeutics and Innovators Landscape 5. The RNA Therapeutics Market 6. RNA Therapeutics: Innovators Landscape 7. RNA Therapeutics: Products Landscape and Company Health Indexing 8. Value Proposition Analysis 9. Company Competitiveness Analysis Section II: Analysis of RNA therapeutics Investment and Company Valuation 10. Funding and Investment Analysis 11. Company Valuation Analysis Section III: Financial Analysis and Assessment of Business Risks 12. Financial Analysis of Public Ventures 13. Company Profiles of Public Ventures 14. Business Risk Assessment Section IV: Market Forecast and Opportunity Analysis 15. Market Forecast and Opportunity Analysis Section V: Analysis of Returns on Investment and Key Acquisition Targets 16. Analysis of Return on Investment 17. Key Acquisition Targets 18. Conclusion 19. Appendices To view more details on this report, click on the link https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market.html Learn from experts: do you know about these emerging industry trends? T-cell Immunotherapies: The Future of Modern Cancer Treatments Monkeypox: Disease Overview, Transmission and Diagnosis Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #RNAtherapeuticsmarketTrends #RNAtherapeuticsmarketGrowth #RNAtherapeuticsmarketopportunities #opportunitiesinRNAtherapeuticsmarket #RNAtherapeuticsfunding

Gene Switch market Growth Opportunity and Industry Forecast to 2035 Gene switches have piqued the interest of adoptive cell therapy developers owing to their ability to enhance safety and control the activity of genetically modified cell products in vivo, while sparing the host immune activity Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Switch Market, 2023-2035” The study features an extensive study of the current market landscape and future opportunity for the players focused on the development of gene switch platforms. Amongst other elements, the report features:  A general overview of gene switches, highlighting details on the basic components of a gene switch and its mechanism of action. It also presents information on the applications and challenges associated with gene switches. In addition, it features a discussion on the future prospects within this domain  A detailed assessment of the current market landscape of gene switch platforms that are under development, based on several relevant parameters  A product competitiveness analysis of the gene switch platforms, based on supplier power and product competitiveness  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in gene switch domain  An analysis of the partnerships that have been inked by stakeholders engaged in this domain, since 2019  An in-depth analysis of the funding and investments that have been made into companies having proprietary gene switch/molecular switch platforms  A detailed analysis of peer-reviewed scientific articles related to research on gene switches, over the last five years  An in-depth analysis of the patents that have been filed / granted related to gene switches, since 2017  A detailed analysis of various business models adopted by the firms developing gene switch platforms, including operational model, service centric model and product centric model  A detailed market forecast for gene switch platforms, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Application Area  Management of Treatment Related Toxicity  Regulation of Gene Expression  Other Applications  Type of Target Therapy  CAR-T cell Therapies  Gene therapies  Other Therapies  Type of Payment Model Employed  Upfront Payment  Milestone Payment  Key Geographical Regions  North America  Europe  Asia Pacific Rest of the World Key companies covered in the report  aceRNA technologies  Autolus Therapeutics  Bellicum Pharmaceuticals  Cellectis  Kiromic BioPharma  panCELLa  Precigen  Sana Biotechnology  Sangamo Therapeutics To view more details on this report, click on the link https://www.rootsanalysis.com/reports/gene-switch-market.html Learn from experts: do you know about these emerging industry trends? Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector Learn from our recently published whitepaper:- Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #GeneSwitchMarketGrowth #GeneSwitchMarketTrends #geneticswitch #syntheticbiology #safetyswitch

Bioreactors and Fermenters market 2023 – Industry Growth by 2035 The COVID-19 pandemic highlighted the imperative need for advanced bioreactor and fermenter systems for the production of novel biopharmaceuticals at various scales of operation. In response to the increased demand for flexible solutions, stakeholders have been actively engaged in developing biomanufacturing equipment with advanced features, including built-in sensors, controllers, and automated systems. Stainless steel bioreactors hold a prominent share (~90%) of the current installed biomanufacturing capacity; majority of this is dedicated to the manufacturing of mammalian and microbial based therapeutics The financial opportunity within the global bioreactors and fermenters market has been analyzed across the following segments:  Type of Product  Bioreactors  Fermenters  Fabrication Material  Glass  Stainless Steel  Single-use  Type of Bioprocess  Batch and Fed-batch  Continuous  Type of Biologic  Antibodies  Vaccines  Cell Therapies  Other Biologics  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World The Global Bioreactors and Fermenters Market, 2023-2035 report also includes profiles of key players (listed below) engaged in manufacturing bioreactors and fermenters; each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.  Applikon Biotechnology  Bionet  Cytiva  Eppendorf  Merck  Ollital Technology  Parr Instrument Company  Sartorius  Shanghai Bailun Biological Technology  Solaris Biotech  Solida Biotech  Zhengzhou Laboao Instrument Equipment (LABAO) Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Bioreactor Manufacturers and Fermenter Manufacturers: Market Landscape 5. Company Competitiveness Analysis 6. Company Profiles 7. Capacity Analysis 8. Case Study: Bioprocess Controllers and Automation Systems 9. Market Sizing and Opportunity Analysis 10. Concluding Remarks 11. Executive Insights 12. Appendix 1: Tabulated Data 13. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #bioreactorsandfermentersmarket #bioreactorsandfermentersmarketsize #fermentermarket #bioreactorsmarket #bioreactormanufacturers

Conjugation and Labeling Services market Professional Survey Report by 2035 The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “Conjugation and Labeling Services Market, 2023-2035” The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes  An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.  A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels.  A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services.  A company competitiveness analysis of conjugation and labeling service providers.  Elaborate profiles of prominent players offering conjugation and labeling services (shortlisted based on a proprietary criterion).  A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.  A detailed analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Molecule  Proteins  Peptides  Small Molecules  Antibodies  Other Molecules  Type of Molecular Conjugate / Label  Polymers  Haptens  Enzymes  Fluorescent Tags  Bead Coupling / Particle Conjugates  Quantum Dots  Isotopes  Other Molecular Conjugates / Labels  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key companies covered in the report  AltaBioscience  Bachem  Bio-Synthesis  Cayman Chemical  CliniSciences  Eurogentec  GBI  Mimotopes  Peptide Institute  piCHEM For additional details, please visit https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? T-cell Immunotherapies: The Future of Modern Cancer Treatments Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #ConjugationandLabelingServicesMarket #ConjugationandLabelingServicesMarketSize #bioconjugation #antibodylabeling #proteinlabeling

Cannabis Testing market Analysis and Trends by 2023-2035 The legalization and recent applications of cannabis for the treatment of certain medical conditions has led to the rise in demand for various cannabis-infused products. These products need to be tested thoroughly, in order to maintain regulatory standards and ensure consumer safety. Following this, cannabis testing services are currently being used across several industries, including healthcare, chemical, cosmetic, agriculture and food. The financial opportunity within the cannabis testing market has been analyzed across the following segments:  Type of Cannabis Tested  Medical Cannabis  Recreational / Adult-use Cannabis  Type of Sample Tested  Flowers  Extracts  Edibles  Others  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The research also includes profiles of key players (listed below) engaged in the cannabis testing market; each profile features a brief overview of the company, details related to its financial information (if available), service portfolio, recent developments, and an informed future outlook.  AccuScience Laboratories  Anresco Labs  CDX Analytics  Coastal Analytical  Eurofins Scientific  EVIO Labs  FoodChain ID  LGC  Medicine Creek Analytics  SGS  Tentamus Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Cannabis Testing Service Providers 5. Cannabis Testing Service Providers: Company Competitiveness Analysis 6. Cannabis Testing Service Providers: Company Profiles 7. Market Landscape: Cannabis Testing Product Providers 8. Partnerships and Collaborations 9. Global Event Analysis 10. Cannabis Testing Services Market: Market Sizing and Opportunity Analysis 11. Concluding Remarks 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/cannabis-testing-market.html News article Non-viral Transfection Reagents and Systems Market Learn from experts: do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Novel Cell Cytometers: Need of the Hour Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #CannabisTestingMarket #CannabisTestingMarketSize #cannabistesting #cannabistestingservicesmarket #medicalcannabistesting

mRNA therapeutics and Vaccines market Trends, Analysis by 2035 Characterized by a rapidly growing pipeline of products, the mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters.  A detailed overview of the current market of players engaged in the development of mRNA therapeutics and vaccines.  An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.  Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and mRNA vaccines.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021).  An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters.  An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters.  An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry.  A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022.  An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Routes of Administration  Intradermal  Intravenous  Intranasal  Others  Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key companies covered in the report  Arcturus Therapeutics  BioNTech and Pfizer  CureVac  Gennova  Moderna  Walvax To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html You may also be interested in the following titles: Gene Switch Market Digital Biomanufacturing Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNA therapeutics and Vaccines Market #mRNAtherapeuticsandVaccinesMarketGrowth #mrnavaccines #mrnabasedvaccines #mrnatherapeutics